OTRK RSI Chart
Last 7 days
-3.7%
Last 30 days
-29.7%
Last 90 days
36.8%
Trailing 12 Months
-90.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 12.9M | 0 | 0 | 0 |
2023 | 11.8M | 10.8M | 11.7M | 12.7M |
2022 | 60.7M | 38.1M | 22.3M | 14.5M |
2021 | 99.2M | 108.5M | 103.1M | 84.1M |
2020 | 40.6M | 50.2M | 65.3M | 82.8M |
2019 | 20.1M | 24.5M | 29.0M | 35.1M |
2018 | 7.8M | 9.4M | 12.6M | 15.2M |
2017 | 8.2M | 8.6M | 8.5M | 7.7M |
2016 | 3.0M | 3.8M | 4.5M | 7.1M |
2015 | 2.3M | 2.4M | 2.6M | 2.7M |
2014 | 836.0K | 1.0M | 1.3M | 2.0M |
2013 | 583.0K | 561.0K | 530.0K | 772.0K |
2012 | 273.0K | 339.0K | 422.0K | 541.0K |
2011 | 412.0K | 364.0K | 317.0K | 267.0K |
2010 | 0 | 1.2M | 808.7K | 448.0K |
2009 | 0 | 0 | 0 | 1.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 20, 2023 | peizer terren s | acquired | 5,416,440 | 0.6 | 9,027,400 | - |
Nov 14, 2023 | peizer terren s | acquired | 16,249,300 | 0.9 | 18,054,800 | - |
Jun 14, 2023 | feld judith | acquired | - | - | 800 | chief medical officer |
Jun 14, 2023 | park james j | sold (taxes) | -131 | 0.4899 | -269 | chief financial officer |
Jun 14, 2023 | park james j | acquired | - | - | 800 | chief financial officer |
Jun 14, 2023 | feld judith | sold (taxes) | -108 | 0.4899 | -222 | chief medical officer |
Feb 21, 2023 | peizer terren s | acquired | - | - | 2,038,130 | ceo and chairman of the board |
Sep 01, 2022 | osborne mary louise | acquired | 13,282 | 0.6641 | 20,000 | chief commercial officer |
Aug 30, 2022 | laverne brandon h | acquired | 13,088 | 0.6544 | 20,000 | chief operating officer |
Aug 29, 2022 | peizer terren s | acquired | - | - | 739,645 | executive chairman |
Which funds bought or sold OTRK recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | COMERICA BANK | unchanged | - | 7.00 | 34.00 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 22,373 | 22,373 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -3.38 | 650 | 3,592 | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | sold off | -100 | -1,157,290 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 78.44 | 689 | 1,238 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -13,221 | - | -% |
May 15, 2024 | Hudson Bay Capital Management LP | reduced | -82.00 | -181,392 | 50,660 | -% |
May 15, 2024 | Royal Bank of Canada | unchanged | - | - | - | -% |
May 14, 2024 | Richard W. Paul & Associates, LLC | unchanged | - | 3.00 | 17.00 | -% |
May 14, 2024 | Qube Research & Technologies Ltd | added | 4,000 | 204 | 208 | -% |
Unveiling Ontrak, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Ontrak, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Ontrak, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -24.3% | 2,680,000 | 3,539,000 | 3,715,000 | 2,960,000 | 2,529,000 | 2,510,000 | 2,843,000 | 3,903,000 | 5,258,000 | 10,332,000 | 18,594,000 | 26,485,000 | 28,722,000 | 29,251,000 | 24,022,000 | 17,226,000 | 12,338,000 | 11,758,000 | 8,845,000 | 7,681,000 | 6,811,000 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,119,000 | 4,365,000 | 3,027,000 |
Gross Profit | -25.4% | 1,705,000 | 2,287,000 | 2,675,000 | 2,156,000 | 1,682,000 | 1,537,000 | 1,407,000 | 1,697,000 | 2,412,000 | 6,243,000 | 12,738,000 | 17,966,000 | 15,972,000 | 15,825,000 | 10,954,000 | 7,350,000 | 5,105,000 | 4,861,000 | 2,726,000 | 3,316,000 | 3,784,000 |
Operating Expenses | -20.3% | 5,978,000 | 7,500,000 | 6,739,000 | 6,784,000 | 8,909,000 | 9,536,000 | 12,470,000 | 13,607,000 | 15,557,000 | 24,225,000 | 18,206,000 | 19,617,000 | 18,852,000 | 17,649,000 | 13,962,000 | 11,437,000 | 11,109,000 | 11,857,000 | 8,322,000 | 8,223,000 | 6,299,000 |
S&GA Expenses | -42.9% | 532,000 | 931,000 | 822,000 | 837,000 | 990,000 | 1,113,000 | 1,151,000 | 1,306,000 | 1,436,000 | 2,056,000 | 2,269,000 | 3,628,000 | 1,942,000 | 1,423,000 | 1,165,000 | 1,060,000 | 877,000 | - | - | - | - |
R&D Expenses | -43.1% | 1,078,000 | 1,893,000 | 1,552,000 | 1,537,000 | 1,644,000 | 1,861,000 | 2,833,000 | 2,852,000 | 3,428,000 | 4,748,000 | 4,563,000 | 4,399,000 | 4,569,000 | 4,908,000 | 3,697,000 | 2,374,000 | 1,944,000 | - | - | - | - |
EBITDA Margin | 14.5% | -1.27 | -1.49 | -1.94 | -2.81 | -3.33 | -3.11 | -2.45 | -1.28 | -0.61 | -0.33 | -0.14 | -0.14 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -84.7% | 183,000 | 1,193,000 | 2,392,000 | 2,223,000 | 1,394,000 | 911,000 | 440,000 | 1,156,000 | 1,400,000 | 1,907,000 | 2,054,000 | 2,029,000 | 2,007,000 | 2,063,000 | 1,818,000 | 1,683,000 | 1,655,000 | 1,665,500 | 589,000 | 471,000 | 321,000 |
Income Taxes | - | - | - | - | -100,000 | 20,000 | -52,000 | 20,000 | 20,000 | 100,000 | 153,000 | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 30.3% | -4,458,000 | -6,396,000 | -6,418,000 | -6,856,000 | -8,330,000 | -9,158,000 | -12,744,000 | -15,038,000 | -14,545,000 | -19,898,000 | -7,883,000 | -3,717,000 | -5,493,000 | - | - | - | - | - | - | - | - |
EBT Margin | 14.8% | -1.87 | -2.20 | -2.63 | -3.42 | -3.84 | -3.55 | -2.79 | -1.51 | -0.76 | -0.44 | -0.23 | -0.22 | - | - | - | - | - | - | - | - | - |
Net Income | 30.3% | -4,458,000 | -6,396,000 | -6,418,000 | -6,756,000 | -8,350,000 | -9,106,000 | -12,764,000 | -15,058,000 | -14,645,000 | -20,051,000 | -7,883,000 | -3,717,000 | -5,493,000 | -3,229,000 | -5,673,000 | -6,213,000 | -7,595,000 | -8,685,000 | -8,563,000 | -5,490,000 | -2,921,000 |
Net Income Margin | 14.9% | -1.86 | -2.19 | -2.61 | -3.41 | -3.84 | -3.55 | -2.80 | -1.51 | -0.76 | -0.44 | -0.20 | -0.17 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 11.0% | -3,296,000 | -3,705,000 | -1,887,000 | -5,213,000 | -4,978,000 | -1,598,000 | -8,555,000 | -4,223,000 | -10,746,000 | -15,659,000 | -15,616,000 | -4,965,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 34.7% | 27.00 | 20.00 | 21.00 | 23.00 | 25.00 | 26.00 | 31.00 | 35.00 | 60.00 | 94.00 | 116 | 133 | 145 | 145 | 83.00 | 25.00 | 23.00 | 24.00 | 24.00 | 16.00 | 7.00 |
Current Assets | -26.2% | 9.00 | 13.00 | 13.00 | 14.00 | 15.00 | 14.00 | 19.00 | 22.00 | 47.00 | 80.00 | 99.00 | 115 | 126 | 124 | 74.00 | 21.00 | 20.00 | 20.00 | 21.00 | 11.00 | 6.00 |
Cash Equivalents | -34.0% | 6.00 | 10.00 | 3.00 | 6.00 | 7.00 | 10.00 | 12.00 | 15.00 | 32.00 | 66.00 | 85.00 | 103 | 107 | 103 | 67.00 | 13.00 | 12.00 | 14.00 | 16.00 | 7.00 | 2.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | -0.2% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | - | - | - | - | - | - | - |
Liabilities | -1.8% | 5.00 | 6.00 | 25.00 | 22.00 | 18.00 | 20.00 | 17.00 | 15.00 | 28.00 | 48.00 | 64.00 | 74.00 | 88.00 | 84.00 | 68.00 | 55.00 | 50.00 | 48.00 | 42.00 | 28.00 | 18.00 |
Current Liabilities | -5.9% | 4.00 | 4.00 | 11.00 | 10.00 | 8.00 | 9.00 | 8.00 | 8.00 | 10.00 | 10.00 | 16.00 | 27.00 | 41.00 | 36.00 | 21.00 | 18.00 | 15.00 | 14.00 | 10.00 | 12.00 | 8.00 |
Long Term Debt | 10.2% | 2.00 | 1.00 | 14.00 | 12.00 | 10.00 | 10.00 | 9.00 | 6.00 | 16.00 | 36.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 35.00 | 33.00 | 32.00 | 30.00 | 14.00 | 9.00 |
LT Debt, Non Current | -100.0% | - | 1.00 | 14.00 | 12.00 | 10.00 | 10.00 | 9.00 | 6.00 | 16.00 | 36.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 35.00 | 33.00 | 32.00 | 30.00 | 14.00 | 9.00 |
Shareholder's Equity | 48.9% | 21.00 | 14.00 | - | 1.00 | 7.00 | 6.00 | 13.00 | 20.00 | 32.00 | 46.00 | 52.00 | 59.00 | 57.00 | 61.00 | 15.00 | - | - | - | - | - | - |
Retained Earnings | -0.9% | -475 | -470 | -464 | -457 | -451 | -442 | -433 | -420 | -405 | -391 | -371 | -363 | -359 | -354 | -350 | -345 | -338 | -331 | -322 | -314 | -308 |
Additional Paid-In Capital | 2.4% | 496 | 485 | 460 | 459 | 458 | 448 | 447 | 441 | 438 | 437 | 423 | 422 | 416 | 415 | 366 | 315 | 311 | 307 | 305 | 302 | 298 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 |
Shares Outstanding | 23.9% | 48.00 | 38.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 8.00 | - | - | - | 12.00 | - | - | - | 305 | - | - | - | 194 | - | - | - | 141 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 9.9% | -3,259 | -3,616 | -1,814 | -5,115 | -4,953 | -1,446 | -8,305 | -3,724 | -10,491 | -15,044 | -14,265 | -3,278 | 6,432 | -198 | -2,534 | -404 | -3,146 | -4,026 | -6,920 | -1,596 | -4,359 |
Share Based Compensation | -42.1% | 352 | 608 | 797 | 892 | 651 | 1,250 | 1,219 | 2,152 | 2,911 | 2,987 | 2,910 | 3,387 | 2,574 | 2,327 | 1,751 | 1,776 | 2,272 | 2,225 | 400 | 1,600 | 1,024 |
Cashflow From Investing | 58.4% | -37.00 | -89.00 | -73.00 | -98.00 | -25.00 | -152 | -250 | -499 | -255 | -615 | -1,351 | -1,687 | -827 | -3,507 | -517 | -600 | -14.00 | - | - | - | - |
Cashflow From Financing | -100.1% | -5.00 | 4,179 | 1,020 | 3,233 | 7,339 | -623 | 5,555 | -12,974 | -23,069 | -3,162 | -2,859 | 1,626 | -2,234 | 39,518 | 57,390 | 1,653 | 1,551 | 1,736 | 15,761 | 7,359 | 2,493 |
Dividend Payments | - | - | - | - | - | - | - | - | - | 2,239 | 2,242 | 2,274 | 2,238 | 2,200 | 1,241 | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 2,680 | $ 2,529 |
Cost of revenue | 975 | 847 |
Gross profit | 1,705 | 1,682 |
Operating expenses: | ||
Research and development | 1,078 | 1,644 |
Sales and marketing | 532 | 990 |
General and administrative | 4,078 | 5,818 |
Restructuring, severance and related charges | 290 | 457 |
Total operating expenses | 5,978 | 8,909 |
Operating loss | (4,273) | (7,227) |
Other (expense) income , net | (2) | 291 |
Interest expense, net | (183) | (1,394) |
Loss before income taxes | (4,458) | (8,330) |
Income tax expense | 0 | (20) |
Net loss | (4,458) | (8,350) |
Dividends on preferred stock - undeclared | (2,239) | (2,239) |
Net loss attributable to common stockholders, basic | (6,697) | (10,589) |
Net loss attributable to common stockholders, diluted | $ (6,697) | $ (10,589) |
Net loss per common share, basic (in dollars per share) | $ (0.11) | $ (2.26) |
Net loss per common share, diluted (in dollars per share) | $ (0.11) | $ (2.26) |
Weighted-average common shares outstanding, basic (in shares) | 60,882 | 4,686 |
Weighted-average common shares outstanding, diluted (in shares) | 60,882 | 4,686 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash | $ 6,400 | $ 9,701 |
Receivables, net | 241 | 0 |
Unbilled receivables | 232 | 207 |
Deferred costs | 119 | 128 |
Prepaid expenses and other current assets | 2,439 | 2,743 |
Total current assets | 9,431 | 12,779 |
Long-term assets: | ||
Property and equipment, net | 757 | 913 |
Goodwill | 5,713 | 5,713 |
Intangible assets, net | 50 | 99 |
Other assets | 10,589 | 147 |
Operating lease right-of-use assets | 183 | 195 |
Total assets | 26,723 | 19,846 |
Current liabilities: | ||
Accounts payable | 667 | 563 |
Accrued compensation and benefits | 756 | 442 |
Deferred revenue | 244 | 97 |
Current portion of operating lease liabilities | 59 | 56 |
Other accrued liabilities | 1,982 | 2,784 |
Total current liabilities | 3,708 | 3,942 |
Long-term liabilities: | ||
Long-term debt, net | 1,617 | 1,467 |
Long-term operating lease liabilities | 151 | 166 |
Total liabilities | 5,476 | 5,575 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; 3,770,265 shares issued and outstanding at each of March 31, 2024 and December 31, 2023 | 0 | 0 |
Common stock, $0.0001 par value; 500,000,000 shares authorized; 43,950,678 and 38,466,979 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 7 | 6 |
Additional paid-in capital | 496,359 | 484,926 |
Accumulated deficit | (475,119) | (470,661) |
Total stockholders' equity | 21,247 | 14,271 |
Total liabilities and stockholders' equity | $ 26,723 | $ 19,846 |